Alerts will be sent to your verified email
Verify Email
SYNGENE
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Syngene International Limited, established in 1993, is a renowned CRMO offering integrated drug discovery and development services. With various certifications and accreditations, the company provides support from lead generation to clinical supplies.
Syngene Internation. major competitors are Piramal Pharma, Laurus Labs, Sun Pharma Adv. Res, Dishman Carbogen Amc, Zenotech Laboratorie, Vivo Bio Tech, Jeevan Scientific.
Market Cap of Syngene Internation. is ₹25,591 Crs.
While the median market cap of its peers are ₹4,122 Crs.
Syngene Internation. seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar Jul | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Dec | ||||||||
| Investor Presentation | Mar Jul | Jun Sep Dec | Mar Jun Sep Dec | Mar Apr Jun Jul Sep Dec | Jan Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | |||||||
| Conference Call | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep Dec | |||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
